Matches in SemOpenAlex for { <https://semopenalex.org/work/W1987068734> ?p ?o ?g. }
- W1987068734 endingPage "811" @default.
- W1987068734 startingPage "803" @default.
- W1987068734 abstract "Thalidomide has received approval from the European Agency for the Evaluation of Medicinal Products for the treatment of newly diagnosed multiple myeloma (MM) patients older than 65 years or ineligible for transplant. The results of five phase III trials assessing thalidomide in combination with melphalan and prednisone (MPT) have demonstrated significantly improved response rates compared with melphalan and prednisone (MP) alone. Additionally, two of these studies showed that survival was extended by approximately 18 months in patients treated with MPT compared with MP alone. Thalidomide, in combination with MP, is associated with adverse events (AEs) including peripheral neuropathy and venous thromboembolism. In order to optimize the efficacy of MPT, a good awareness of these AEs is imperative. This manuscript outlines both evidence- and consensus-based recommendations discussed by a panel of experts, to provide a practical guide for physicians addressing the effective management of newly diagnosed, transplant-ineligible MM patients receiving thalidomide therapy." @default.
- W1987068734 created "2016-06-24" @default.
- W1987068734 creator A5001068881 @default.
- W1987068734 creator A5006799794 @default.
- W1987068734 creator A5011827756 @default.
- W1987068734 creator A5016246851 @default.
- W1987068734 creator A5020357934 @default.
- W1987068734 creator A5031837957 @default.
- W1987068734 creator A5034560778 @default.
- W1987068734 creator A5059482051 @default.
- W1987068734 creator A5059967673 @default.
- W1987068734 creator A5071589084 @default.
- W1987068734 creator A5087769225 @default.
- W1987068734 date "2010-03-16" @default.
- W1987068734 modified "2023-10-14" @default.
- W1987068734 title "Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myeloma" @default.
- W1987068734 cites W1516067462 @default.
- W1987068734 cites W1572386607 @default.
- W1987068734 cites W1966156828 @default.
- W1987068734 cites W1970309861 @default.
- W1987068734 cites W1976709963 @default.
- W1987068734 cites W1979050146 @default.
- W1987068734 cites W1984949744 @default.
- W1987068734 cites W1985658104 @default.
- W1987068734 cites W1988898930 @default.
- W1987068734 cites W1991524278 @default.
- W1987068734 cites W1992745410 @default.
- W1987068734 cites W1994721812 @default.
- W1987068734 cites W1997680923 @default.
- W1987068734 cites W2000080558 @default.
- W1987068734 cites W2000364384 @default.
- W1987068734 cites W2001133874 @default.
- W1987068734 cites W2004903490 @default.
- W1987068734 cites W2007086823 @default.
- W1987068734 cites W2015111816 @default.
- W1987068734 cites W2018076602 @default.
- W1987068734 cites W2018491765 @default.
- W1987068734 cites W2027913637 @default.
- W1987068734 cites W2029243558 @default.
- W1987068734 cites W2032411201 @default.
- W1987068734 cites W2039166615 @default.
- W1987068734 cites W2043306284 @default.
- W1987068734 cites W2045550256 @default.
- W1987068734 cites W2070682538 @default.
- W1987068734 cites W2073154438 @default.
- W1987068734 cites W2079738711 @default.
- W1987068734 cites W2082741854 @default.
- W1987068734 cites W2084605742 @default.
- W1987068734 cites W2088540908 @default.
- W1987068734 cites W2096207943 @default.
- W1987068734 cites W2097087602 @default.
- W1987068734 cites W2097331346 @default.
- W1987068734 cites W2100398815 @default.
- W1987068734 cites W2101466538 @default.
- W1987068734 cites W2101576302 @default.
- W1987068734 cites W2103660186 @default.
- W1987068734 cites W2106226048 @default.
- W1987068734 cites W2106783894 @default.
- W1987068734 cites W2110466835 @default.
- W1987068734 cites W2113101033 @default.
- W1987068734 cites W2117172636 @default.
- W1987068734 cites W2118820477 @default.
- W1987068734 cites W2120161314 @default.
- W1987068734 cites W2129534936 @default.
- W1987068734 cites W2132918724 @default.
- W1987068734 cites W2134165426 @default.
- W1987068734 cites W2136226957 @default.
- W1987068734 cites W2136373453 @default.
- W1987068734 cites W2136795385 @default.
- W1987068734 cites W2137984904 @default.
- W1987068734 cites W2143756652 @default.
- W1987068734 cites W2148188974 @default.
- W1987068734 cites W2149634568 @default.
- W1987068734 cites W2156623257 @default.
- W1987068734 cites W2160165070 @default.
- W1987068734 cites W2160972799 @default.
- W1987068734 cites W2167560182 @default.
- W1987068734 cites W2180726212 @default.
- W1987068734 cites W2316160054 @default.
- W1987068734 cites W2547124264 @default.
- W1987068734 cites W2594070503 @default.
- W1987068734 cites W4241442958 @default.
- W1987068734 cites W4252667026 @default.
- W1987068734 doi "https://doi.org/10.1007/s00277-010-0925-1" @default.
- W1987068734 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20232066" @default.
- W1987068734 hasPublicationYear "2010" @default.
- W1987068734 type Work @default.
- W1987068734 sameAs 1987068734 @default.
- W1987068734 citedByCount "31" @default.
- W1987068734 countsByYear W19870687342012 @default.
- W1987068734 countsByYear W19870687342013 @default.
- W1987068734 countsByYear W19870687342014 @default.
- W1987068734 countsByYear W19870687342015 @default.
- W1987068734 countsByYear W19870687342016 @default.
- W1987068734 countsByYear W19870687342017 @default.
- W1987068734 countsByYear W19870687342018 @default.
- W1987068734 countsByYear W19870687342019 @default.
- W1987068734 countsByYear W19870687342022 @default.